Blood sample vial near pregnant belly to depict mother’s health check.
Every year in India, hundreds of thousands of women give birth in circumstances that carry a risk most people never think about: the risk of bleeding to death.
Postpartum haemorrhage — severe bleeding after delivery — is the single leading cause of maternal mortality globally, responsible for approximately 25–34% of all maternal deaths. In Asia, it accounts for around 31% of maternal fatalities. India, with one of the world's highest absolute numbers of births, carries a substantial share of this global burden.
Access to safe, compatible blood — available quickly, in the right quantity, at the right facility — is one of the eight key life-saving functions that the World Health Organisation identifies as essential for comprehensive emergency obstetric care. Without it, a haemorrhaging mother cannot be saved regardless of how skilled the medical team is.
India's blood transfusion data reflects this reality starkly: obstetrics and gynaecology accounts for 3.3 million units — or 22.4% of India's entire annual blood demand. That is the third-largest category of blood use in the country, behind only general medicine and surgery.
India has made significant progress in reducing maternal mortality over the past two decades. The Maternal Mortality Ratio (MMR) has fallen substantially — from over 300 deaths per 100,000 live births in the early 2000s to significantly lower figures today, though the country still has a long way to go to reach the WHO target of below 70.
Despite this progress, the absolute numbers remain large. India accounts for approximately 20% of global maternal deaths — driven by its enormous birth volume, uneven healthcare infrastructure, and persistent anaemia burden among women of reproductive age.
Haemorrhage remains the leading obstetric emergency requiring immediate blood transfusion. A study in an Indian obstetric unit found that obstetric haemorrhage was the most common indication for blood transfusion in pregnant and postpartum women.
Anaemia — which affects an estimated 50–60% of pregnant women in India — is the second major driver. Women entering labour with severely low haemoglobin levels have virtually no physiological reserve to tolerate blood loss during delivery. Even a blood loss that a healthy woman would manage without intervention can be life-threatening for a severely anaemic mother.
The nature of obstetric haemorrhage makes blood transfusion uniquely urgent.
Unlike planned surgical blood loss — which is anticipated, measured, and managed — postpartum bleeding is unpredictable. It can occur suddenly, progress rapidly, and require massive transfusion in a very short window.
A woman can lose 1 litre of blood in minutes during a severe postpartum haemorrhage. Without transfusion, the resulting hypovolemic shock can be fatal within an hour. Clinical guidelines recommend that when haemorrhage is severe and uncontrolled, O-negative blood — the universal donor type — should be administered immediately, without waiting for crossmatching, to buy time while compatible blood is prepared.
This is why blood banks attached to maternity hospitals and obstetric units must maintain constant, adequate stocks. A delay of even 30–60 minutes in sourcing blood during an acute obstetric haemorrhage can be fatal.
Packed Red Blood Cells (PRBCs):
The most commonly transfused product for obstetric haemorrhage and anaemia. Restores oxygen-carrying capacity and intravascular volume.
Fresh Frozen Plasma (FFP):
Used when haemorrhage is accompanied by coagulation factor depletion — a condition called disseminated intravascular coagulation (DIC) that can develop during severe obstetric emergencies. FFP restores clotting factors that are being consumed faster than the body can replace them.
Platelets:
Required when platelet counts fall critically during massive haemorrhage or specific obstetric conditions like HELLP syndrome (haemolysis, elevated liver enzymes, low platelets) — a serious complication of pre-eclampsia.
Cryoprecipitate:
Used for specific clotting factor deficiencies (particularly fibrinogen) during DIC.
The FOGSI (Federation of Obstetric and Gynaecological Societies of India) guidelines on blood transfusion in obstetrics specify that all Rh-negative women must receive Rh-D-negative blood — making O-negative blood particularly critical for emergency obstetric situations, as Rh-negative women of childbearing age who receive Rh-positive blood can develop antibodies that would damage a future foetus's blood cells.
Blood transfusion is life-saving in obstetric emergencies — but only if it is available.
India's obstetric blood access problem has a stark geographic dimension. A global surgery study found that 150,000 pregnancy-related deaths globally could be averted each year through access to safe blood. In India, a significant proportion of maternal deaths from haemorrhage occur not because the condition was untreatable but because blood was not available at the facility where the delivery occurred.
Over 80% of India's primary healthcare centres lack a blood storage facility — despite the National Blood Policy requiring them to have 24/7 blood transfusion services. This means a woman who delivers at a PHC and experiences postpartum haemorrhage must be transported to a facility with blood — a journey that, in rural India, can take hours.
During that journey, without transfusion, survival is uncertain.
This infrastructure gap is precisely where platforms like TheBloodApp have potential impact: by enabling faster identification of voluntary donors near a medical facility, the gap between the moment blood is needed and the moment it is available can be compressed — sometimes decisively.
The blood transfusion problem in Indian obstetrics begins before delivery.
India has some of the world's highest rates of anaemia in pregnant women — estimated at 50–60% of pregnant women nationally, with rates exceeding 70% in some states. Anaemia is defined as haemoglobin below 11 g/dL in pregnant women; severe anaemia is below 7 g/dL.
Clinical guidelines recommend blood transfusion when haemoglobin falls below 7 g/dL in pregnancy, because the oxygen-carrying capacity at that level is dangerously low for both mother and foetus. A transfusion before delivery ensures the mother enters labour with some physiological reserve.
This pre-delivery transfusion demand is a major component of the 3.3 million units attributed to obstetrics and gynaecology annually — and it is a demand that cannot be deferred, because pregnancy progresses regardless of blood bank stock levels.
When you donate blood voluntarily through TheBloodApp or at a blood bank in your city, your donation enters a system that directly supports obstetric care:
You will likely never know the specific patient. But the connection is real — traceable through the blood bank's records from your donation to a transfusion requisition from an obstetric ward.
The 3.3 million units needed annually for obstetrics and gynaecology are not an abstract statistical requirement. They represent 3.3 million potential moments — each one a mother, a newborn, and a family — where the right blood, in time, is the difference that matters.
Given that the most acute obstetric blood demand serves women, it is worth noting that women's participation in India's blood donation system is still severely underrepresented. Only 6% of India's voluntary blood donors are women, according to available survey data.
Anaemia — the most common reason women are deferred at blood banks — is both a health problem and a social one. Iron-deficient diets, insufficient dietary diversity, and cultural norms around women's health contribute to deferral rates.
Women who maintain adequate haemoglobin through iron-rich diets and appropriate nutrition are both healthier and more able to donate blood. A woman who donates blood every 4 months (as per NBTC guidelines) contributes to the same blood supply that may one day save her own mother, sister, or friend.
Register on TheBloodApp today. Donate blood regularly. Every unit you contribute has a direct potential path to a mother in labour, a woman in a haemorrhage emergency, or a pregnant patient in an anaemia crisis somewhere in India. To find donation camps and blood banks near you, call the number listed in the app.
Sources: PMC — Blood Transfusion Services Maharashtra and Gujarat | PMC — Use of Blood in Obstetrics and Gynecology Developing World | FOGSI — Blood Transfusion in Obstetrics and Gynecology Guidelines 2024 | PLOS ONE — National Blood Demand Study | WHO — Blood Safety and Maternal Health | Journal of Reproduction, Contraception, Obstetrics 2024 — Blood Transfusion Indications | WHO India Blood Safety Report 2024
Stay informed, stay inspired — your go-to source for everything about blood donation and impact.
Obstetrics and gynaecology accounts for 22.4% of India's annual blood demand. Postpartum haemorrhage is the leading cause of maternal mortality globally. Here's how your blood donation directly saves mothers' lives.
Sickle cell anemia affects millions across India's tribal populations — and depends on regular blood transfusions for survival. Here's the data, the impact, and what voluntary donors can do.
Bengaluru has a young, tech-savvy, health-conscious population — and one of India's most advanced blood banking ecosystems. Here's a complete guide to donating blood in Bengaluru.
Be a part of the change — donate safely, stay connected, and help someone in need. Download the app today.
Available on
